Consistent with our findings, knockdown of NCOA3 decreased cell proliferation, colony formation, and tumorigenesis of CRC cells in vitro and in vivo (Mo et al., 2015), suggested that MAD2L2 was a novel regulator of NCOA3 in CRC progression. This evidence concerns the gene MAD2L2 and colorectal carcinoma.